Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL9567157 | 0.98 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRB | |
| SCHEMBL20364 | 0.91 | — | — | |
| SCHEMBL10762910 | 0.91 | — | — | |
| SCHEMBL27553112 | 0.91 | TSHR (0.48) | ALDH1A1TSHRTHRB | |
| SCHEMBL11125870 | 0.91 | — | — | |
| Ethylene SCHEMBL8934253 | 0.89 | TSHR (0.46) | ALDH1A1TSHRTHRB | |
| Water SCHEMBL10713209 | 0.89 | TSHR (0.46) | ALDH1A1TSHRTHRB | |
| SCHEMBL20701419 | 0.89 | TSHR (0.46) | ALDH1A1TSHRTHRB | |
| SCHEMBL28133850 | 0.89 | TSHR (0.46) | ALDH1A1TSHRTHRB | |
| Acetone SCHEMBL8653588 | 0.89 | TSHR (0.46) | ALDH1A1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103901722-B | Alkaline imaging photosensitive resin composition and preparation method thereof | 无锡德贝尔光电材料有限公司 | 2017-02-22 | — | — | CN | claimed |
| US-20260061009-A1 | METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION | SERNOVA CORP (CA) | 2026-03-05 | — | — | US | disclosed |
| US-20260021169-A1 | CO-TRANSPLANTATION OF MMP-9 ENHANCED MESENCHYMAL STEM CELLS AND PANCREATIC ISLETS FOR THE TREATMENT OF DIABETES | UNIV MARYLAND (US) | 2026-01-22 | — | — | US | disclosed |
| US-20230347018-A1 | METHODS AND DEVICES FOR CELLULAR TRANSPLANTATION | SERNOVA CORP (CA) | 2023-11-02 | — | — | US | disclosed |
| US-11730860-B2 | Methods and devices for cellular transplantation | SERNOVA CORPORATION (CA) | 2023-08-22 | — | — | US | disclosed |
| US-20220211770-A1 | METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION | SERNOVA CORPORATION (CA) | 2022-07-07 | — | — | US | disclosed |
| EP-3962505-A1 | METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION | Sernova Corporation (CA) | 2022-03-09 | — | — | EP | disclosed |
| WO-2020223670-A1 | METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION | SERNOVA CORPORATION (CA) | 2020-11-05 | — | — | WO | disclosed |
| EP-3290061-B1 | METHODS AND DEVICES FOR CELLULAR TRANSPLANTATION | SERNOVA CORP (CA) | 2020-06-10 | — | — | EP | disclosed |
| US-20190240375-A1 | METHODS AND DEVICES FOR CELLULAR TRANSPLANTATION | SERNOVA CORPORATION (CA) | 2019-08-08 | — | — | US | disclosed |
| WO-2007047509-A2 | DIFFERENTIATION OF NON-EMBRYONIC STEM CELLS TO CELLS HAVING A PANCREATIC PHENOTYPE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20060286141-A1 | Systems for gel-based medical implants | ENDOLUMEN THERAPEUTICS, INC. | 2006-12-21 | — | — | US | disclosed |
| WO-2006086639-A1 | VASCULAR/LYMPHATIC ENDOTHELIAL CELLS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2006-08-17 | — | — | WO | disclosed |
| CN-1809617-A | Transfer film for plasma display panel, plasma display panel, and method for producing same | JSR CORP (JP) | 2006-07-26 | — | — | CN | disclosed |
| WO-2005058200-A1 | SYSTEMS FOR GEL-BASED MEDICAL IMPLANTS | ENDOLUMEN THERAPEUTICS, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| US-5369169-A | Polymer blends with enhanced properties | ROHM AND HAAS COMPANY (US) | 1994-11-29 | — | — | US | disclosed |
| US-5296537-A | Gas barriers | ROHM AND HAAS COMPANY (US) | 1994-03-22 | — | — | US | disclosed |
| US-5208083-A | (meth)acrylate and/or glutarimide containing polymer mixed with vinyl alcohol polymer; oxygen barrier; containers | ROHM AND HAAS COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| US-5147930-A | Vapor barriers; blends of alkyl (meth)acrylate and/or glutarimide polymers with vinyl alcohol polymers | ROHM AND HAAS COMPANY (US) | 1992-09-15 | — | — | US | disclosed |
| EP-0373911-A1 | Polymer blends with enhanced properties | ROHM AND HAAS COMPANY (US) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021169-A1 | CO-TRANSPLANTATION OF MMP-9 ENHANCED MESENCHYMAL STEM CELLS AND PANCREATIC ISLETS FOR THE TREATMENT OF DIABETES | MMP9, MMP1, IAPP | ALDH1A1 710/4885TSHR 2764/4885THRB 2594/4885 |
| US-20260061009-A1 | METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION | IAPP, PGF, INSR | ALDH1A1 3557/4885TSHR 1498/4885THRB 1661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.